The Revolutionizing Insulin Pump

In the rapidly advancing world of medical technology, the launch of the revolutionizing Insulin Pump marks a significant leap forward in diabetes care. This innovative product, which has recently received FDA approval and is set for a widespread release in the first quarter of 2024, represents a paradigm shift in how individuals with diabetes manage their condition. Unlike its predecessor, the Insulin Pump boasts a more compact design and introduces the groundbreaking feature of being controllable via an iPhone. This integration with smartphone technology not only enhances user convenience but also empowers users with greater control over their insulin management.

The Advanced Insulin Pump – A Significant Leap Forward In Diabetes Care

A pivotal element in the development of the Insulin Pump is the collaboration between the pump manufacturer and Nanomotion. This partnership has culminated in the creation of a sophisticated drive mechanism at the heart of the pump, which relies.

Nanomotion’s innovations in direct drive, low voltage miniature motors have revolutionized the design and functionality of medical devices, particularly evident in their unique size and performance. These elements, fundamental to the pump’s operation, enable it to deliver precise doses of insulin with unparalleled accuracy. Notably, Nanomotion’s Edge motors have facilitated a significant redesign of the pump’s internal architecture. In contrast, the new design incorporates quadrants linked by internal electrodes, with external electrodes produced through cold spattering. This innovative method dramatically reduces thermal exposure to less than 90°C and narrows the electrode thickness to a slim 2-3 micrometers.

Nanomotion’s Piezo Motors

This advancement is not just a testament to Nanomotion’s expertise in piezo motors but also marks a significant leap in the precise dosing and miniaturization of medical devices. Through these contributions, Nanomotion underscores its commitment to enhancing the efficiency and reliability of medical technologies, paving the way for future developments in the field.

The Insulin Pump, with its compact size and smartphone control capability, coupled with the technological advancements brought about by Nanomotion’s expertise, stands as a game-changer in diabetes care. It exemplifies how collaboration at the intersection of medical science and technology can lead to groundbreaking solutions that improve the lives of individuals with chronic conditions.

Nanomotion’s team consists of engineering resources with more than 100 man years of precision motion control experience. The true measure of reliability is to evaluate our motor performance on a system designed and manufactured by Nanomotion.

For more information, please contact Nanomotion by email, call +1 (631) 585-3000,